Discontinuation of disease modifying therapies is associated with disability progression regardless of prior stable disease and age.
- DOI
- 10.1016/j.msard.2021.103406
- Published
- 2022 Jan
- Container
- Multiple sclerosis and related disorders
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.msard.2021.103406,
title = {Discontinuation of disease modifying therapies is associated with disability progression regardless of prior stable disease and age.},
author = {Jakimovski D and Kavak KS and Vaughn CB and Goodman AD and Coyle PK and Krupp L and Gottesman M and Edwards KR and Lenihan M and Perel A and Zivadinov R and Weinstock-Guttman B and New York State Multiple Sclerosis Consortium (NYSMSC)},
year = {2022},
journal = {Multiple sclerosis and related disorders},
doi = {10.1016/j.msard.2021.103406},
url = {https://doi.org/10.1016/j.msard.2021.103406}
}RIS
TY - JOUR TI - Discontinuation of disease modifying therapies is associated with disability progression regardless of prior stable disease and age. AU - Jakimovski D AU - Kavak KS AU - Vaughn CB AU - Goodman AD AU - Coyle PK AU - Krupp L AU - Gottesman M AU - Edwards KR AU - Lenihan M AU - Perel A AU - Zivadinov R AU - Weinstock-Guttman B AU - New York State Multiple Sclerosis Consortium (NYSMSC) PY - 2022 JO - Multiple sclerosis and related disorders DO - 10.1016/j.msard.2021.103406 UR - https://doi.org/10.1016/j.msard.2021.103406 ER -
APA
D, J., KS, K., CB, V., AD, G., PK, C., L, K., M, G., KR, E., M, L., A, P., R, Z., B, W., & (NYSMSC), N. Y. S. M. S. C. (2022). Discontinuation of disease modifying therapies is associated with disability progression regardless of prior stable disease and age.. Multiple sclerosis and related disorders. https://doi.org/10.1016/j.msard.2021.103406
Source records
- pubmed · retrieved 2026-09-26T08:35:03.285Z